The Interleukin-33/Growth Stimulation Expressed Gene 2 Signaling Axis in Transplantation: Context-Dependent Roles and Clinical Implications
Journal of Visualized Experiments · 2026-10-30 · (236)
DOI: 10.3791/72314 ↗At a glance
Video/Audio in Journal of Visualized Experiments, published online on 2026-10-30. Written by Hongjie Ying and 2 co-authors. Institution: Kidney Disease Center, Zhejiang University. Major MEDLINE topics: Interleukin-1 Receptor-Like 1 Protein, Interleukin-33, Organ Transplantation.
Abstract (original language)
This article comprehensively summarizes the expression, mechanisms of action, and clinical significance of the IL-33/ST2 axis in solid organ transplantation and hematopoietic stem cell transplantation. Rather than being uniformly protective or pathogenic, the IL-33/ST2 axis exerts context-dependent effects: ST2L, expressed on regulatory T cells, group 2 innate lymphoid cells, and Th2 cells, promotes immune tolerance, whereas sST2 acts as a decoy receptor that blocks this pathway and promotes inflammation and fibrosis. The net effect depends on tissue-specific innate immune cell composition, differential ST2 isoform expression, donor versus recipient compartment, intervention timing and dosage, and the degree of ischemia-reperfusion injury. Clinically, elevated sST2 is associated with antibody-mediated rejection in kidney transplantation, graft dysfunction in heart transplantation, and treatment-refractory graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. However, these are primarily observational associations; direct causal evidence from genetic or pharmacological intervention studies remains limited and is often derived from animal models. Comparative analysis across transplant types reveals that sST2 may complement established biomarkers such as donor-derived cell-free DNA and donor-specific antibodies, particularly for chronic graft fibrosis and DSA-negative rejection. Future research should use single-cell and spatial transcriptomics to characterize the dynamic expression of ST2 isoforms across immune cells and transplant stages, and explore strategies to induce immune tolerance targeting the IL-33/ST2 axis to improve long-term outcomes for transplant patients.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Kidney Disease Center, Zhejiang University.
- Institute of Nephropathy, Zhejiang University.
- Zhejiang Clinical Research Center of Kidney and Urinary System Disease.
- Zhejiang Clinical Research Center of Kidney and Urinary System Disease; jianghong961106@zju.edu.cn.
Cite
APA
Ying, H., Feng, S., & Jiang, H. (2026). The Interleukin-33/Growth Stimulation Expressed Gene 2 Signaling Axis in Transplantation: Context-Dependent Roles and Clinical Implications. Journal of Visualized Experiments. https://doi.org/10.3791/72314
Vancouver
Ying H, Feng S, Jiang H. The Interleukin-33/Growth Stimulation Expressed Gene 2 Signaling Axis in Transplantation: Context-Dependent Roles and Clinical Implications. Journal of Visualized Experiments. 2026. doi:10.3791/72314
BibTeX
@article{Ying2026,
author = {Ying, Hongjie and Feng, Shi and Jiang, Hong},
title = {The Interleukin-33/Growth Stimulation Expressed Gene 2 Signaling Axis in Transplantation: Context-Dependent Roles and Clinical Implications},
journal = {Journal of Visualized Experiments},
year = {2026},
number = {236},
doi = {10.3791/72314}
}
EUVIMED